172
Views
0
CrossRef citations to date
0
Altmetric
CASE SERIES

The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series

, , , , &
Pages 2357-2363 | Received 24 May 2023, Accepted 29 Jul 2023, Published online: 29 Aug 2023

References

  • Tan KW, Haylett AK, Ling TC, et al. Comparison of demographic and photobiological features of chronic actinic dermatitis in patients with lighter vs darker skin types. JAMA Dermatol. 2017;153:427–435. doi:10.1001/jamadermatol.2016.5861
  • Agarwal P, Agarwal US, Meena RS, et al. A combination of oral azathioprine and methotrexate in difficult to treat dermatoses. Indian J Dermatol Ve. 2017;83:389–392.
  • Forsyth EL, Millard TP. Diagnosis and pharmacological treatment of chronic actinic dermatitis in the elderly: an update. Drug Aging. 2010;27(6):451–456. doi:10.2165/11315930-000000000-00000
  • Mastorino L, Viola R, Panzone M, et al. Dupilumab induces a rapid decrease of pruritus in adolescents: a pilot real-life study. Dermatol Ther. 2021;34(6):e15115. doi:10.1111/dth.15115
  • Mastorino L, Rosset F, Gelato F, et al. Chronic pruritus in atopic patients treated with dupilumab: real life response and related parameters in 354 patients. Pharmaceuticals-Base. 2022;15.
  • Mastorino L, Cantafio DV, Vecco C, et al. Impact of comorbidities in the response of atopic patients treated with dupilumab: a real-life study up to 36 weeks. J Eur Acad Dermatol. 2022;36(12):e1021–3. doi:10.1111/jdv.18427
  • Miniotti M, Ribero S, Mastorino L, et al. Long-term psychological outcome of patients with moderate-to-severe atopic dermatitis continuously treated with Dupilumab: data up to 3 years. Exp Dermatol. 2023;32(6):852–858. doi:10.1111/exd.14786
  • Ali K, Wu L, Lou H, et al. Clearance of chronic actinic dermatitis with dupilumab therapy in Chinese patients: a case series. Front Med-Lausanne. 2022;9:803692. doi:10.3389/fmed.2022.803692
  • McFeely O, Doyle C, Blasco MC, et al. Chronic actinic dermatitis successfully treated with methotrexate and dupilumab. Photodermatol Photo. 2022:57.
  • Chen JC, Lian CH. Chronic actinic dermatitis in an old adult significantly improved by dupilumab. Photodermatol Photo. 2022;38(2):176–177. doi:10.1111/phpp.12731
  • Chen J, Li H, Zhu H. Successful treatment of chronic actinic dermatitis with dupilumab: a case report and review of the literature. Clin Cosmet Inv Derm. 2021;14:1913–1917. doi:10.2147/CCID.S342401
  • Patel N, Konda S, Lim HW. Dupilumab for the treatment of chronic actinic dermatitis. Photodermatol Photo. 2020;36(5):398–400. doi:10.1111/phpp.12566
  • Verma L, Pratt M. A case report of therapeutically challenging chronic actinic dermatitis. Sage Open Med Case R. 2019;7:2050313X19845235.
  • Hawk JL. Chronic actinic dermatitis. Photodermatol Photo. 2004;20(6):312–314. doi:10.1111/j.1600-0781.2004.00129.x
  • Ko DY, Choi SH, Ha SM, et al. The clinical severity score of chronic actinic dermatitis correlates with in vivo photoallergic reactions and the immunologic parameters related to a shift towards Th2 immunity from the Th2/Th1 balanced status in patients with chronic actinic dermatitis. Photodermatol Photo. 2016;32(4):199–206. doi:10.1111/phpp.12244
  • Gu Q, Zhang Z, Yang J, et al. Chronic actinic dermatitis: a 5-year clinical analysis of 488 patients in China. Photodermatol Photo. 2022.
  • Safa G, Pieto-Le CC, Hervagault B. Recalcitrant chronic actinic dermatitis treated with low-dose thalidomide. J Am Acad Dermatol. 2005;52(5):E6. doi:10.1016/S0190-9622(03)01131-9
  • Ullrich SE. Does exposure to UV radiation induce a shift to a Th-2-like immune reaction? Photochem Photobiol. 1996;64(2):254–258. doi:10.1111/j.1751-1097.1996.tb02454.x
  • Kim JH, Kim HJ, Yoo DW, et al. A postulated model for photo immunopathogenesis of chronic actinic dermatitis around adaptive immunity, including Th17 cells, Tregs, TRMs, cytotoxic T cells, and/or common-gamma chain receptor+ cells. Photodermatol Photo. 2022.
  • Quatrano NA, Shvartsbeyn M, Meehan SA, et al. Chronic actinic dermatitis occurring in an adult with atopic dermatitis. Dermatol Online J. 2015;21.